Literature DB >> 1378480

Bovine coronavirus peplomer glycoproteins: detailed antigenic analyses of S1, S2 and HE.

J F Vautherot1, M F Madelaine, P Boireau, J Laporte.   

Abstract

Forty-four monoclonal antibodies (MAbs) to the G110 isolate of bovine enteric coronavirus were used for the characterization of the peplomer proteins S and HE. Fourteen of these MAbs reacted with HE and the remaining 30 with the products of the S gene, S1 (19 MAbs), S2 (six MAbs) and gp200 (five MAbs). S1 and HE were found to carry major neutralization determinants, and S1 appeared to elicit the production of the MAbs displaying the highest neutralizing activity. The topography of the epitopes was assessed by means of a competitive binding assay; the 44 MAbs defined four independent antigenic domains on S1, two on S2, one on gp200 and two on HE. All the neutralizing anti-S1 MAbs mapped in antigenic sites A and B and all the neutralizing anti-HE MAbs in HE-B. Antigenic site S1-B was further subdivided into four subsites. Functional mapping was performed by testing a library of neutralization-resistant mutants against the neutralizing MAbs. Analysis of their reactivity in a neutralization test confirmed the overall distribution of epitopes in S1-B and HE-B.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378480     DOI: 10.1099/0022-1317-73-7-1725

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  Characterization of Marek's disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth.

Authors:  Fabien Dorange; B Karsten Tischer; Jean-François Vautherot; Nikolaus Osterrieder
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Characterization of monoclonal antibodies to the hemagglutinin-esterase glycoprotein of a bovine coronavirus associated with winter dysentery and cross-reactivity to field isolates.

Authors:  G Milane; A B Kourtesis; S Dea
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

3.  Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection.

Authors:  S Laurent; J F Vautherot; M F Madelaine; G Le Gall; D Rasschaert
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

4.  Detection and characterization of bovine coronaviruses in fecal specimens of adult cattle with diarrhea during the warmer seasons.

Authors:  Su-Jin Park; Cheol Jeong; Soon-Seek Yoon; Hyoun E Choy; Linda J Saif; Sung-Hee Park; You-Jung Kim; Jae-Ho Jeong; Sang-Ik Park; Ha-Hyun Kim; Bong-Joo Lee; Ho-Seong Cho; Sang-Ki Kim; Mun-Il Kang; Kyoung-Oh Cho
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

5.  High-level expression of Marek's disease virus glycoprotein C is detrimental to virus growth in vitro.

Authors:  B Karsten Tischer; Daniel Schumacher; Danièlle Chabanne-Vautherot; Vladimir Zelnik; Jean-François Vautherot; Nikolaus Osterrieder
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Genomic relationship of porcine hemagglutinating encephalomyelitis virus to bovine coronavirus and human coronavirus OC43 as studied by the use of bovine coronavirus S gene-specific probes.

Authors:  E Vieler; T Schlapp; C Anders; W Herbst
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

7.  Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.

Authors:  Hong Zhang; Guangwen Wang; Jian Li; Yuchun Nie; Xuanling Shi; Gewei Lian; Wei Wang; Xiaolei Yin; Yang Zhao; Xiuxia Qu; Mingxiao Ding; Hongkui Deng
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  Characterization of monoclonal antibodies to bovine enteric coronavirus and antigenic variability among Quebec isolates.

Authors:  L Michaud; S Dea
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates.

Authors:  Jie Li; Laura Ulitzky; Erica Silberstein; Deborah R Taylor; Raphael Viscidi
Journal:  Viral Immunol       Date:  2013-04       Impact factor: 2.257

10.  Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: implications for the functional roles of S2 subunit.

Authors:  Fanya Zeng; Chung Chau Hon; Chi Wai Yip; Ka Man Law; Yin Shan Yeung; Kwok Hung Chan; Joseph S Malik Peiris; Frederick Chi Ching Leung
Journal:  FEBS Lett       Date:  2006-09-12       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.